Dutch national guidelines for locally recurrent rectal cancer

Floor Piqeur1, Davy M J Creemers2, Evi Banken3

  • 1Department of Radiation Oncology, Catharina Hospital, Michelangelolaan 2 5623EJ, Eindhoven, the Netherlands; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121 1066 CX, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Centre, Albinusdreef 2 2333ZA, Leiden, the Netherlands.

PubMed
Summary

Local rectal cancer recurrence (LRRC) affects 6-12% of patients despite improved primary treatments. This guideline provides comprehensive management strategies for LRRC, addressing complex cases and guiding clinical decisions.